PAMELA ISLEY: Open Payments
NPI 1528211760 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 19 payments from 11 companies in 2025. Trend: 2023 $281 · 2024 $465 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $187 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Calliditas Therapeutics US Inc. | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Apellis Pharmaceuticals, Inc. | 1 | $34 |
| Lilly USA, LLC | 1 | $27 |
| Fresenius USA Marketing, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
Products named: Ozempic, JYNARQUE, TARPEYO, JARDIANCE, Fabhalta, Wegovy, VELPHORO, ULTOMIRIS.
Industry payments across CO — which companies pay providers there.
